Last reviewed · How we verify

NCT04492696

Comparison of Concussion Education Programs

Completed NA Last updated 30 July 2020
What this trial tests

NA trial testing Education in Concussion, Brain in 118 participants. Completed in 31 October 2018.

Timeline
1 August 2018
Primary endpoint
31 October 2018
31 October 2018

Quick facts

Lead sponsorStanford University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment118
Start date1 August 2018
Primary completion31 October 2018
Estimated completion31 October 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

Adults 14 to 19, male only, with Concussion, Brain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Importance: Concussion underreporting leads to delays in diagnosis and treatment, resulting in prolonged recovery. Athletes' report of concussion symptoms is therefore an important component of risk reduction. Numerous educational interventions to improve concussion knowledge and reporting exist. Objective: Evaluate the comparative efficacy of three concussion education programs in improving concussion-reporting intention. Design: Randomized clinical trial conducted from August 2018 to October 2018, with assessment before, immediately after, and one-month after educational intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Education

Trials testing the same drug.

Other recruiting trials for Concussion, Brain

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04492696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing